multi class comparison

Oral Diabetes Drugs: Metformin vs Sulfonylureas vs SGLT2 vs GLP-1 — MOA, Hypo Risk, Key Warnings

Four drug classes, four completely different risk profiles. Pick the wrong one on NCLEX and you'll miss that only sulfonylureas cause true hypoglycemia, only metformin demands a contrast-dye hold, and SGLT2 inhibitors can trigger DKA even with normal glucose. Each class has a signature danger — mix them up and you'll choose the wrong teaching point.

Comparison

Side-by-side4 compared
Comparevs
Dimension
Metformin
Sulfonylureas
SGLT2 Inhibitors
GLP-1 Agonists
Class & mechanism
  • Biguanide: ↓ hepatic glucose, ↑ insulin sensitivity
  • ↑ pancreatic insulin secretion
  • ↑ urinary glucose excretion
  • Incretin: glucose-dependent insulin, ↓ glucagon
Indications
  • First-line T2DM
  • T2DM, glipizide & glyburide
  • T2DM with CV or renal benefit
  • T2DM, semaglutide & liraglutide
Route
  • PO
  • PO
  • PO, the "-flozins"
  • SubQ injection — not oral
Key assessment
  • Renal function (eGFR) before dosing
  • Hypoglycemia signs
  • Volume status, genital/UTI symptoms
  • GI tolerance, nausea & vomiting
Monitoring labs
  • Monitor A1c & blood glucose
  • Monitor A1c & blood glucose
  • Monitor A1c & blood glucose
  • Monitor A1c & blood glucose
Adverse effects
  • GI upset, B12 deficiency
  • No hypoglycemia alone, weight-neutral
  • HYPOglycemia + weight gain
  • Genital/UTI infections, volume depletion
  • Nausea/vomiting, weight loss
Black box & toxicity
  • Lactic acidosis — hold for IV contrast
  • Severe hypoglycemia, esp. glyburide
  • Euglycemic DKA — ketones despite normal BG
  • Thyroid C-cell tumor risk (black box)
Contraindications
  • Hold if eGFR <30 or IV contrast
  • Sulfa allergy; caution in elderly
  • Recurrent genital infection, hypovolemia
  • Personal/family medullary thyroid CA, MEN2
Patient teaching
  • Take with food to ↓ GI upset
  • Take with meals
  • Carry fast sugar for lows
  • Hydrate; perineal hygiene to prevent infection
  • Rotate SubQ sites; expect early nausea
Class & mechanism

Metformin

  • Biguanide: ↓ hepatic glucose, ↑ insulin sensitivity

Sulfonylureas

  • ↑ pancreatic insulin secretion
Indications

Metformin

  • First-line T2DM

Sulfonylureas

  • T2DM, glipizide & glyburide
Route

Metformin

  • PO

Sulfonylureas

  • PO
Key assessment

Metformin

  • Renal function (eGFR) before dosing

Sulfonylureas

  • Hypoglycemia signs
Monitoring labs

Metformin

  • Monitor A1c & blood glucose

Sulfonylureas

  • Monitor A1c & blood glucose
Adverse effects

Metformin

  • GI upset, B12 deficiency
  • No hypoglycemia alone, weight-neutral

Sulfonylureas

  • HYPOglycemia + weight gain
Black box & toxicity

Metformin

  • Lactic acidosis — hold for IV contrast

Sulfonylureas

  • Severe hypoglycemia, esp. glyburide
Contraindications

Metformin

  • Hold if eGFR <30 or IV contrast

Sulfonylureas

  • Sulfa allergy; caution in elderly
Patient teaching

Metformin

  • Take with food to ↓ GI upset

Sulfonylureas

  • Take with meals
  • Carry fast sugar for lows

marks the fact that sets a column apart.

Clinical Pearl

Sulfonylureas cause hypo, metformin demands a contrast hold, SGLT2 causes UTI + euglycemic DKA — match the danger to the drug.

⚡ Speed Sort This Table

Swipe to sort 107 clinical items into the right bucket

Component Topics